PHENTRIALS.COM KEYWORD DENSITY CHECKER

Total words: 764 | 2-word phrases: 199 | 3-word phrases: 212 | 4-word phrases: 214

PAGE INFO

Title Try to keep the title under 60 characters (90 characters)
PHENTrials.com - Increasing Participation in Prostate Cancer Clinical Trials to Save Lives
Description Try to keep the meta description between 50 - 160 characters (412 characters)
PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives Find Your Trial PHEN’s “Find Your Trial (FYT)” search tool connects patients with prostate cancer clinical trials with where you are on your prostate cancer journey. Select your diagnosis below. Low Risk Intermediate Risk High Risk Cancer Recurrence Non-Metastatic Castration Resistant Metastatic Castration Sensitive
Keywords Meta keywords are not recommended anymore (0 characters)
H1 No H1 tag on the page (0 characters)

ONE WORD PHRASES 139 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1trials75.04%
2to64.32%
3clinical64.32%
4cancer64.32%
5prostate64.32%
6for53.60%
7and53.60%
8patient42.88%
9your42.88%
10is42.88%

TWO WORD PHRASES 199 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1clinical trial63.02%
2clinical trials52.51%
3metastatic castration42.01%
4prostate cancer42.01%
5your trial21.01%
6cancer clinical21.01%
7is for21.01%
8prostate health21.01%
9about phen21.01%
10being tested10.50%
11tested in10.50%
12trials it10.50%
13it is10.50%
14is designed10.50%
15designed to10.50%
16617 481402010.50%
17to block10.50%
18drug being10.50%
19two checkpoints10.50%
20checkpoints telling10.50%

THREE WORD PHRASES 212 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1prostate cancer clinical20.94%
2cancer clinical trials20.94%
3617 4814020 email protected10.47%
4clinical trials it10.47%
5summary lorigerlimab is10.47%
6lorigerlimab is an10.47%
7is an investigational10.47%
8an investigational drug10.47%
9investigational drug being10.47%
10drug being tested10.47%
11being tested in10.47%
12trials it is10.47%
13prostate health lorikeet10.47%
14it is designed10.47%
15is designed to10.47%
16designed to block10.47%
17to block two10.47%
18block two checkpoints10.47%
19two checkpoints telling10.47%
20checkpoints telling the10.47%
21immune system cells10.47%
22system cells to10.47%
23health lorikeet patient10.47%
24visit prostate health10.47%
25to wake up10.47%
26to respond to10.47%
27trial is for10.47%
28is for patients10.47%
29for patients who10.47%
30have metastatic castration10.47%

FOUR WORD PHRASES 214 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1prostate cancer clinical trials20.93%
2an investigational drug being10.47%
3not both and to10.47%
4taxanebased chemotherapy visit prostate10.47%
5chemotherapy visit prostate health10.47%
6visit prostate health lorikeet10.47%
7prostate health lorikeet patient10.47%
8summary lorigerlimab is an10.47%
9lorigerlimab is an investigational10.47%
10is an investigational drug10.47%
11617 4814020 email protected facebook10.47%
12enzalutamide but not both10.47%
13investigational drug being tested10.47%
14drug being tested in10.47%
15clinical trials it is10.47%
16trials it is designed10.47%
17it is designed to10.47%
18is designed to block10.47%
19designed to block two10.47%
20to block two checkpoints10.47%
21but not both and10.47%
22or enzalutamide but not10.47%
23two checkpoints telling the10.47%
24have metastatic castration resistant10.47%
25for amg509 patient summary10.47%
26amg509 patient summary this10.47%
27patient summary this clinical10.47%
28summary this clinical trial10.47%
29this clinical trial is10.47%
30clinical trial is for10.47%
31trial is for patients10.47%
32is for patients who10.47%
33metastatic castration resistant prostate10.47%
34acetate or enzalutamide but10.47%
354814020 email protected facebook facebook10.47%
36resistant prostate cancer mcrpc10.47%
37prostate cancer mcrpc and10.47%
38cancer mcrpc and failed10.47%
39to respond to abiraterone10.47%
40respond to abiraterone acetate10.47%

EXTERNAL LINKS

# URL Whois Check